Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1

Conditions

Uterine Cervical Neoplasms 10Neoplasms 9Breast Neoplasms 9Colorectal Neoplasms 8Lung Neoplasms 5Papillomavirus Infections 3Uterine Cervical Dysplasia 2Prostatic Neoplasms 2Pancreatic Neoplasms 2Neoplasm Metastasis 2Heart Diseases 2HIV Infections 2Gastrointestinal Neoplasms 2Esophageal Neoplasms 2End Stage Liver Disease 2the Rate of Participation in Screening for PBC 1Warts 1Venous Thromboembolism 1Uterine Cervical Diseases 1Urinary Bladder Neoplasms 1Tinea 1Squamous Intraepithelial Lesions 1Squamous Cell Carcinoma of Head and Neck 1Smoking 1Skin Neoplasms 1Retinoblastoma 1Radiation Injuries 1Pulmonary Atelectasis 1Postural Orthostatic Tachycardia Syndrome 1Postoperative Complications 1

Interventions

Surveys and Questionnaires 2Mass Screening 1Focus Groups 1Blood Specimen Collection 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Lung Cancer Screening × Mass Screening × Clear all
NCT07408531 2026-04-13

LUNG-07: Advancing Precision-Based Lung Cancer Screening: Implementation, AI-Guided Risk Stratification, and Biomarker Integration (CREST AI)

University of Illinois at Chicago

Phase NA Recruiting
2,500 enrolled
Thoracic

Lung Cancer Screening

Data powered by HemOnc (CC BY 4.0) Colophon âš¡